Vitalhub closes $74.75-million bought deal offering

Executive Summary

• Vitalhub Corp. has closed a bought deal public offering of common shares, raising approximately $74.75 million in gross proceeds.
• The offering included the full exercise of the over-allotment option, resulting in the sale of 5,885,828 common shares at a price of $12.70 per share.
• Net proceeds are designated for a growth initiative focused on acquiring third-party enterprises in the healthcare industry to create synergistic opportunities.

Key Details

• Transaction Structure: Bought deal public offering with full exercise of the over-allotment option.
• Gross Proceeds: Approximately $74.75 million.
• Share Price: $12.70 per common share.
• Shares Sold: 5,885,828 common shares.
• Underwriters: Co-led by Cormark Securities Inc. and National Bank Financial Inc., with participation from Canaccord Genuity Corp., Scotia Capital Inc., and TD Securities Inc.
• Regulatory Filings: Qualified for distribution via a prospectus supplement dated Aug. 15, 2025, to the base shelf prospectus dated July 23, 2025 (filed in Ontario, British Columbia, and Alberta).
• US Distribution: Sold in the United States on a private placement basis pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933.
• Listing Status: Common shares have been conditionally approved for listing on the Toronto Stock Exchange (TSX), subject to final approval.
• Use of Proceeds: Net proceeds to be used for the company's growth initiative, specifically targeting future acquisitions of third-party enterprises in the healthcare industry.

Notable Quotes

• No direct quotes from executives were included in the provided text.